Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Riva, Agostino"" wg kryterium: Autor


Tytuł :
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.
Autorzy :
Moiola L; Multiple Sclerosis Center and Neurology Department, IRCCS Ospedale San Raffaele, Milan, Italy.
Barcella V; Department of Neurology and Multiple Sclerosis Center, ASST 'Papa Giovanni XXIII', Bergamo, Italy.
Benatti S; Department of Infectious Diseases, ASST 'Papa Giovanni XXIII', Bergamo, Italy.
Capobianco M; SCDO Neurology and Regional Reference Multiple Sclerosis Center, A.O.U. San Luigi, Orbassano, Italy.
Capra R; Multiple Sclerosis Center, Spedali Civili of Brescia, Montichiari, Italy.
Cinque P; Division of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
Comi G; The Institute of Experimental Neurology and Multiple Sclerosis Center IRCCS, San Raffaele Hospital, Milan.
Fasolo MM; Division of Infectious Diseases, Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Franzetti F; Infectious Diseases Unit, Busto Arsizio Hospital, Busto Arsizio, Italy/Luigi Sacco University Hospital, III Division of Infectious Diseases, Milan and Infectious Diseases Unit, Busto Arsizio, Italy.
Galli M; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Department of Biomedical and Clinical Sciences 'L.Sacco', University of Milan, Italy.
Gerevini S; Division of Neuroradiology, IRCCS San Raffaele Scientific Institute, Milan, Italy/Neuroradiology Department, 'Papa Giovanni XXIII' Hospital, Bergamo, Italy.
Meroni L; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, University of Milan, Italy.
Origoni M; Department of Gynecology and Obstetrics, Vita Salute San Raffaele University, IRCCS Ospedale San Raffaele, Milan, Italy.
Prosperini L; Department of Neuroscience, San Camillo-Forlanini Hospital, Rome, Italy.
Puoti M; SC Infectious Diseases ASST Niguarda Ca Grande Hospital, Milan, Italy.
Scarpazza C; Multiple Sclerosis Center, Spedali Civili of Brescia, Montichiari, Italy/Department of General Psychology, University of Padova, Padova, Italy.
Tortorella C; Department of Neuroscience, San Camillo-Forlanini Hospital, Rome, Italy.
Zaffaroni M; Multiple Sclerosis Center, Hospital of Gallarate, ASST della Valle Olona, Gallarate, Italy.
Riva A; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, University of Milan, Milan, Italy.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Mar; Vol. 27 (3), pp. 331-346. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.
Autorzy :
Riva A; III Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, L. Sacco Hospital, Milan, Italy.
Barcella V; Department of Neurology and Multiple Sclerosis Center, ASST Papa Giovanni XXIII, Bergamo, Italy.
Benatti SV; Department of Infectious Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy.
Capobianco M; SCDO Neurology and Regional Reference Multiple Sclerosis Center, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, Italy.
Capra R; Multiple Sclerosis Center, Spedali Civili of Brescia, Montichiari, Italy.
Cinque P; Division of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy/Institute of Experimental Neurology and Multiple Sclerosis Center IRCCS, San Raffaele Hospital, Milan, Italy.
Comi G; Institute of Experimental Neurology and Multiple Sclerosis Center IRCCS, San Raffaele Hospital, Milan, Italy.
Fasolo MM; Division of Infectious Diseases, Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, University Hospital, Milan, Italy.
Franzetti F; Infectious Diseases Unit, Busto Arsizio Hospital, Varese, Italy.
Galli M; Department of Clinical Sciences, Luigi Sacco Hospital, University of Milan, Milan, Italy.
Gerevini S; Division of Neuroradiology, IRCCS San Raffaele Scientific Institute, Milan, Italy; Neuroradiology Department, ASST Papa Giovanni XXIII, Bergamo, Italy.
Meroni L; III Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, L. Sacco Hospital, Milan, Italy.
Origoni M; Department of Gynecology and Obstetrics, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Milano, Italy.
Prosperini L; Department of Neuroscience, San Camillo-Forlanini Hospital, Rome, Italy.
Puoti M; SC Infectious Diseases, ASST Niguarda Ca' Grande Hospital, Milan, Italy.
Scarpazza C; Multiple Sclerosis Center, Spedali Civili of Brescia, Montichiari, Italy/Department of General Psychology, University of Padova, Padova, Italy.
Tortorella C; Department of Neuroscience, San Camillo-Forlanini Hospital, Rome, Italy.
Zaffaroni M; Multiple Sclerosis Center, Hospital of Gallarate, ASST della Valle Olona, Gallarate, Italy.
Moiola L; Multiple Sclerosis Center, IRCCS San Raffaele Hospital, Milan, Italy/Neurology Department, IRCCS San Raffaele Hospital, Milan, Italy.
Pokaż więcej
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Mar; Vol. 27 (3), pp. 347-359. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Dolutegravir is not associated with weight gain in ART experienced geriatric patients living with HIV.
Autorzy :
Guaraldi G; Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy Department of Molecular and Translational Medicine, University of Brescia, Italy Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Italy Division of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia and ASST Spedali Civili of Brescia Third Division of Infectious Diseases, University of Milan, Ospedale L. Sacco, Milano, Italy ARNAS 'Garibaldi' UOC Malattie Infettive Catania, Italy First Division of Infectious Diseases Unit, University of Milan, Ospedale L. Sacco, Italy Department of Medicine, Infectious Diseases Unit, Azienda Ospedaliera di Perugia and University of Perugia, Santa Maria Hospital, Perugia, Italy Unit of Infectious Diseases, Department of Internal Medicine, Azienda Ospedaliera-Universitaria di Padova, Italy Unit of Infectious Diseases, Division A, Ospedale Amedeo di Savoia, Turin, Italy Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
Calza S
Milic J
Calcagno A
Focà E
Rota M
Renzetti S
Celotti A
Siano M
Celesia BM
Piconi S
de Socio GV
Cattelan AM
Orofino G
Riva A
Nozza S
di Perri G
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2021 Feb 23. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
Autorzy :
Thomson EC; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Rosen LE; Vir Biotechnology, San Francisco, CA 94158, USA.
Shepherd JG; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Spreafico R; Vir Biotechnology, San Francisco, CA 94158, USA.
da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Wojcechowskyj JA; Vir Biotechnology, San Francisco, CA 94158, USA.
Davis C; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Piccoli L; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Pascall DJ; Institute of Biodiversity, Animal Health and Comparative Medicine, Boyd Orr Centre for Population and Ecosystem Health, University of Glasgow, Glasgow G61 1QH, UK.
Dillen J; Vir Biotechnology, San Francisco, CA 94158, USA.
Lytras S; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Czudnochowski N; Vir Biotechnology, San Francisco, CA 94158, USA.
Shah R; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Meury M; Vir Biotechnology, San Francisco, CA 94158, USA.
Jesudason N; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Li K; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Bassi J; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
O'Toole A; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
Pinto D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Colquhoun RM; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
Culap K; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Jackson B; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Rambaut A; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK.
Jaconi S; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Sreenu VB; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Nix J; Molecular Biology Consortium, Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
Zhang I; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Tri-Institutional PhD Program in Computational Biology and Medicine, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.
Jarrett RF; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Glass WG; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Beltramello M; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Nomikou K; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Pizzuto M; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Tong L; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Croll TI; Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK.
Johnson N; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Di Iulio J; Vir Biotechnology, San Francisco, CA 94158, USA.
Wickenhagen A; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Ceschi A; Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland.
Harbison AM; Department of Chemistry and Hamilton Institute, Maynooth University, Maynooth, Ireland.
Mair D; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Ferrari P; Department of Nephrology, Ospedale Civico Lugano, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Prince of Wales Hospital Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
Smollett K; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Sallusto F; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland; ETH Institute of Microbiology, ETH Zurich, 8093 Zürich, Switzerland.
Carmichael S; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
Nichols J; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Galli M; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, Italy.
Hughes J; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Riva A; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, Italy.
Ho A; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Schiuma M; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, Italy.
Semple MG; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7BE, UK; Respiratory Medicine, Alder Hey Children's Hospital, Liverpool L12 2AP, UK.
Openshaw PJM; National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.
Fadda E; Department of Chemistry and Hamilton Institute, Maynooth University, Maynooth, Ireland.
Baillie JK; The Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK; Intensive Care Unit, Royal Infirmary Edinburgh, Edinburgh EH16 4SA, UK.
Chodera JD; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Rihn SJ; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
Lycett SJ; The Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK.
Virgin HW; Vir Biotechnology, San Francisco, CA 94158, USA; Washington University School of Medicine, Saint Louis, MO 63110, USA.
Telenti A; Vir Biotechnology, San Francisco, CA 94158, USA.
Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
Robertson DL; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK. Electronic address: .
Snell G; Vir Biotechnology, San Francisco, CA 94158, USA. Electronic address: .
Pokaż więcej
Corporate Authors :
ISARIC4C Investigators; ISARIC4C Investigators.
COVID-19 Genomics UK (COG-UK) Consortium; https://www.cogconsortium.uk.
Źródło :
Cell [Cell] 2021 Jan 28. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.
Autorzy :
Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institut Pasteur and CNRS UMR 3569, Unité de Virologie Structurale, Paris, France.
Beltramello M; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Lempp FA; Vir Biotechnology, San Francisco, CA 94158, USA.
Pinto D; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Dang HV; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Rosen LE; Vir Biotechnology, San Francisco, CA 94158, USA.
McCallum M; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Bowen J; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Minola A; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Jaconi S; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Zatta F; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
De Marco A; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Guarino B; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Bianchi S; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Lauron EJ; Vir Biotechnology, San Francisco, CA 94158, USA.
Tucker H; Vir Biotechnology, San Francisco, CA 94158, USA.
Zhou J; Vir Biotechnology, San Francisco, CA 94158, USA.
Peter A; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Havenar-Daughton C; Vir Biotechnology, San Francisco, CA 94158, USA.
Wojcechowskyj JA; Vir Biotechnology, San Francisco, CA 94158, USA.
Case JB; Departments of Medicine, Molecular Microbiology, Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Chen RE; Departments of Medicine, Molecular Microbiology, Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Kaiser H; Vir Biotechnology, San Francisco, CA 94158, USA.
Montiel-Ruiz M; Vir Biotechnology, San Francisco, CA 94158, USA.
Meury M; Vir Biotechnology, San Francisco, CA 94158, USA.
Czudnochowski N; Vir Biotechnology, San Francisco, CA 94158, USA.
Spreafico R; Vir Biotechnology, San Francisco, CA 94158, USA.
Dillen J; Vir Biotechnology, San Francisco, CA 94158, USA.
Ng C; Vir Biotechnology, San Francisco, CA 94158, USA.
Sprugasci N; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Culap K; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Benigni F; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Abdelnabi R; Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Belgium.
Foo SC; Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Belgium.
Schmid MA; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Cameroni E; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Riva A; III Division of Infectious Diseases, Luigi Sacco University Hospital, University of Milan, Italy.
Gabrieli A; III Division of Infectious Diseases, Luigi Sacco University Hospital, University of Milan, Italy.
Galli M; III Division of Infectious Diseases, Luigi Sacco University Hospital, University of Milan, Italy.
Pizzuto MS; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Neyts J; Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Belgium.
Diamond MS; Departments of Medicine, Molecular Microbiology, Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Virgin HW; Vir Biotechnology, San Francisco, CA 94158, USA.; Washington University School of Medicine, St. Louis, MO, USA.; UTSouthwestern Medical Center, Dallas, TX, USA.
Snell G; Vir Biotechnology, San Francisco, CA 94158, USA.
Corti D; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Fink K; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. .
Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. .
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2020 Nov 20; Vol. 370 (6519), pp. 950-957. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Betacoronavirus/*immunology
Coronavirus Infections/*prevention & control
Pandemics/*prevention & control
Peptidyl-Dipeptidase A/*immunology
Pneumonia, Viral/*prevention & control
Spike Glycoprotein, Coronavirus/*antagonists & inhibitors
Amino Acid Motifs/immunology ; Angiotensin-Converting Enzyme 2 ; Animals ; Antibodies, Neutralizing/administration & dosage ; Antibodies, Neutralizing/isolation & purification ; Antibodies, Viral/administration & dosage ; Antibodies, Viral/isolation & purification ; CHO Cells ; COVID-19 ; Coronavirus Infections/therapy ; Cricetinae ; Cricetulus ; Cryoelectron Microscopy ; HEK293 Cells ; Humans ; Immunodominant Epitopes/chemistry ; Immunodominant Epitopes/immunology ; Microscopy, Electron ; Pneumonia, Viral/therapy ; Protein Domains/immunology ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/immunology
Czasopismo naukowe
Tytuł :
Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19.
Autorzy :
Gervasoni C; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Meraviglia P; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Riva A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Giacomelli A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Oreni L; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Minisci D; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Atzori C; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Ridolfo A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Cattaneo D; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Nov 19; Vol. 71 (16), pp. 2276-2278.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19/*complications
HIV Infections/*complications
Adult ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Female ; Hospitalization ; Humans ; Italy ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Risk Factors ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Autorzy :
Piccoli L; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Park YJ; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institut Pasteur and CNRS UMR 3569, Unité de Virologie Structurale, 75015 Paris, France.
Czudnochowski N; Vir Biotechnology, San Francisco, CA 94158, USA.
Walls AC; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Beltramello M; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Silacci-Fregni C; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Pinto D; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Rosen LE; Vir Biotechnology, San Francisco, CA 94158, USA.
Bowen JE; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Acton OJ; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Jaconi S; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Guarino B; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Minola A; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Zatta F; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Sprugasci N; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Bassi J; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Peter A; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
De Marco A; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Nix JC; Molecular Biology Consortium, Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
Mele F; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.
Jovic S; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.
Rodriguez BF; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.
Gupta SV; Vir Biotechnology, San Francisco, CA 94158, USA.
Jin F; Vir Biotechnology, San Francisco, CA 94158, USA.
Piumatti G; Division of Primary Care, Geneva University Hospitals, 1205 Geneva, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland.
Lo Presti G; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
Pellanda AF; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
Biggiogero M; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
Tarkowski M; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, Italy.
Pizzuto MS; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Cameroni E; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Havenar-Daughton C; Vir Biotechnology, San Francisco, CA 94158, USA.
Smithey M; Vir Biotechnology, San Francisco, CA 94158, USA.
Hong D; Vir Biotechnology, San Francisco, CA 94158, USA.
Lepori V; Independent Physician, 6500 Bellinzona, Switzerland.
Albanese E; Institute of Public Health, Università della Svizzera italiana, 6900 Lugano, Switzerland.
Ceschi A; Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900 Lugano, Switzerland; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland.
Bernasconi E; Division of Infectious Diseases, Ente Ospedaliero Cantonale, Ospedale Civico and Ospedale Italiano, 6900 Lugano, Switzerland.
Elzi L; Division of Infectious Diseases, Ente Ospedaliero Cantonale, Ospedale Regionale Bellinzona e Valli and Ospedale Regionale, 6600 Locarno, Switzerland.
Ferrari P; Department of Nephrology, Ospedale Civico Lugano, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Prince of Wales Hospital Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.
Riva A; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, 20157 Milan, Italy.
Snell G; Vir Biotechnology, San Francisco, CA 94158, USA.
Sallusto F; Institute for Research in Biomedicine, Università della Svizzera italiana, 6500 Bellinzona, Switzerland.
Fink K; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Virgin HW; Vir Biotechnology, San Francisco, CA 94158, USA.
Lanzavecchia A; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland.
Corti D; Humabs BioMed SA, Vir Biotechnology, 6500 Bellinzona, Switzerland. Electronic address: .
Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell [Cell] 2020 Nov 12; Vol. 183 (4), pp. 1024-1042.e21. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Neutralizing/*immunology
Epitope Mapping/*methods
Spike Glycoprotein, Coronavirus/*immunology
Angiotensin-Converting Enzyme 2 ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/genetics ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/chemistry ; Antibodies, Viral/blood ; Antibodies, Viral/chemistry ; Antibodies, Viral/immunology ; Antigen-Antibody Reactions ; Betacoronavirus/immunology ; Betacoronavirus/isolation & purification ; Betacoronavirus/metabolism ; Binding Sites ; COVID-19 ; Coronavirus Infections/pathology ; Coronavirus Infections/virology ; Epitopes/chemistry ; Epitopes/immunology ; Humans ; Immunoglobulin A/blood ; Immunoglobulin A/immunology ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Immunoglobulin M/blood ; Immunoglobulin M/immunology ; Kinetics ; Molecular Dynamics Simulation ; Pandemics ; Peptidyl-Dipeptidase A/chemistry ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/pathology ; Pneumonia, Viral/virology ; Protein Binding ; Protein Domains/immunology ; Protein Structure, Quaternary ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/metabolism
Czasopismo naukowe
Tytuł :
Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy.
Autorzy :
Zehender G; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.; EpiSoMi CRC-Coordinated Research Center, University of Milan, Milan, Italy.; Romeo ed Enrica Invernizzi Pediatric Research Center, University of Milan, Milan, Italy.
Lai A; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.; EpiSoMi CRC-Coordinated Research Center, University of Milan, Milan, Italy.
Bergna A; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
Meroni L; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Riva A; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Balotta C; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
Tarkowski M; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
Gabrieli A; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
Bernacchia D; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Rusconi S; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Rizzardini G; Department of Infectious Diseases, Luigi Sacco Hospital, Milan, Italy.
Antinori S; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Galli M; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.; EpiSoMi CRC-Coordinated Research Center, University of Milan, Milan, Italy.; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2020 Sep; Vol. 92 (9), pp. 1637-1640. Date of Electronic Publication: 2020 Apr 10.
Typ publikacji :
Journal Article
MeSH Terms :
Genome, Viral*
Genomics*/methods
Phylogeny*
COVID-19/*epidemiology
COVID-19/*virology
SARS-CoV-2/*classification
SARS-CoV-2/*genetics
Computational Biology/methods ; Humans ; Italy/epidemiology ; Regression Analysis
Czasopismo naukowe
Tytuł :
Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report.
Autorzy :
Riva A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Cattaneo D; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Filice C; Infectious Diseases Department, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Gervasoni C; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Pokaż więcej
Źródło :
International journal of STD & AIDS [Int J STD AIDS] 2020 Sep; Vol. 31 (10), pp. 1008-1010. Date of Electronic Publication: 2020 Jul 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Does lopinavir really inhibit SARS-CoV-2?
Autorzy :
Cattaneo D; Unit of Clinical Pharmacology, Fatebenefratelli Sacco University Hospital, Milan, Italy.
Cattaneo D; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Gervasoni C; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy. Electronic address: .
Corbellino M; rd Division of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Galli M; rd Division of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Riva A; rd Division of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Gervasoni C; rd Division of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Clementi E; Unit of Clinical Pharmacology Fatebenefratelli Sacco University Hospital, Department of Biomedical and Clinical Sciences L. Sacco, Università di Milano, Milan, Italy.
Clementi E; IRCCS E. Nedea Scientific Institute, Bosisio Parini, Italy.
Pokaż więcej
Źródło :
Pharmacological research [Pharmacol Res] 2020 Aug; Vol. 158, pp. 104898. Date of Electronic Publication: 2020 May 11.
Typ publikacji :
Letter; Comment
MeSH Terms :
Coronavirus Infections*/drug therapy
Pandemics*
Pneumonia, Viral*
SARS Virus*
Adenosine Monophosphate/analogs & derivatives ; Alanine/analogs & derivatives ; Betacoronavirus ; COVID-19 ; Emetine ; Homoharringtonine ; Humans ; Lopinavir ; SARS-CoV-2
SCR Protocol :
COVID-19 drug treatment
Opinia redakcyjna
Tytuł :
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study.
Autorzy :
Giacomelli A; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy. Electronic address: .
Ridolfo AL; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
Milazzo L; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
Oreni L; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
Bernacchia D; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Siano M; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Bonazzetti C; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Covizzi A; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Schiuma M; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Passerini M; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Piscaglia M; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Coen M; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
Gubertini G; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
Rizzardini G; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
Cogliati C; Department of Internal Medicine, ASST Fatebenefratelli-Sacco, Luigi Sacco Hospital, Milan, Italy.
Brambilla AM; Department of Emergency Medicine, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
Colombo R; Department of Anesthesiology and Intensive Care, ASST Fatebenefratelli-Sacco, Luigi Sacco Hospital, Milan, Italy.
Castelli A; Department of Anesthesiology and Intensive Care, ASST Fatebenefratelli-Sacco, Luigi Sacco Hospital, Milan, Italy.
Rech R; Department of Anesthesiology and Intensive Care, ASST Fatebenefratelli-Sacco, Luigi Sacco Hospital, Milan, Italy.
Riva A; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
Torre A; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
Meroni L; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.
Rusconi S; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Antinori S; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Galli M; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy; Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Italy.
Pokaż więcej
Źródło :
Pharmacological research [Pharmacol Res] 2020 Aug; Vol. 158, pp. 104931. Date of Electronic Publication: 2020 May 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Betacoronavirus*
Coronavirus Infections/*mortality
Hospitalization/*statistics & numerical data
Pneumonia, Viral/*mortality
Age Factors ; Aged ; COVID-19 ; Female ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Pandemics ; Prospective Studies ; Risk Factors ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Dosing of Dolutegravir in TB/HIV Coinfected Patients on Rifampicin: Twice Is (Always) Better Than Once.
Autorzy :
Cattaneo D; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Department of Infectious Diseases, Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Riva A; Third Division of Infectious Diseases, Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Columpsi P; Unit of Infectious Diseases, ASST, Monza University Hospital, Monza, Italy.
Lapadula G; Unit of Infectious Diseases, ASST, Monza University Hospital, Monza, Italy.
Filice C; Infectious Diseases Department, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Gervasoni C; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Third Division of Infectious Diseases, Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Pokaż więcej
Źródło :
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2020 Jul 01; Vol. 84 (3), pp. e17-e20.
Typ publikacji :
Letter
MeSH Terms :
HIV Infections/*drug therapy
Heterocyclic Compounds, 3-Ring/*therapeutic use
Oxazines/*therapeutic use
Piperazines/*therapeutic use
Pyridones/*therapeutic use
Rifampin/*therapeutic use
Tuberculosis/*drug therapy
Adult ; Aged ; Coinfection/drug therapy ; Female ; HIV Integrase Inhibitors/therapeutic use ; Humans ; Male ; Middle Aged ; Rifampin/administration & dosage
Opinia redakcyjna
Tytuł :
Darunavir does not prevent SARS-CoV-2 infection in HIV patients.
Autorzy :
Riva A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Conti F; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Bernacchia D; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Pezzati L; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Sollima S; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Merli S; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Siano M; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Lupo A; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Rusconi S; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy.
Cattaneo D; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
Gervasoni C; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milano, Italy; Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy. Electronic address: .
Pokaż więcej
Źródło :
Pharmacological research [Pharmacol Res] 2020 Jul; Vol. 157, pp. 104826. Date of Electronic Publication: 2020 Apr 20.
Typ publikacji :
Letter; Comment
MeSH Terms :
HIV Infections*
Ritonavir*
Betacoronavirus ; COVID-19 ; Coronavirus Infections ; Darunavir ; Humans ; Lopinavir ; Pandemics ; Pneumonia, Viral ; Republic of Korea ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases.
Autorzy :
Guerrini G; Department of Medical Sciences, Section of Rheumatology, University of Ferrara, Italy.
Franzetti F; Infectious Disease Unit, Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Italy.
Giacomelli R; Rheumatology Unit, Department of Biotechnological and Applied Clinical Science, School of Medicine, University of L'Aquila, Italy.
Meroni L; Infectious Disease Unit, Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Italy.
Riva A; Infectious Disease Unit, Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Italy.
Scirè CA; Department of Medical Sciences, Section of Rheumatology, University of Ferrara, Italy.
Scrivo R; Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Italy.
Tavio M; Division of Infectious Diseases, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy.
Agostinone A; Unità di Malattie Infettive, Ospedale Civile Spirito Santo, Pescara, Italy.
Airò P; Rheumatology and Clinical Immunology Unit, Spedali Civili of Brescia, Italy.
Atzeni F; Department of Internal Medicine and Medical Therapy, Section of Rheumatology, University of Messina, Italy.
Bartalesi F; Department of Experimental and Clinical Medicine, University of Florence, and Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Bazzichi L; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Berardicurti O; Rheumatology Unit, Department of Biotechnological and Applied Clinical Science, School of Medicine, University of L'Aquila, Italy.
Cassola G; Infectious Diseases Unit, Galliera Hospital, Genoa, Italy.
Castagna A; Clinic of Infectious Diseases, Vita-Salute San Raffaele University, Milano, Italy.
Castelli F; University Department of Infectious and Tropical Diseases, University of Brescia and Spedali Civili General Hospital, Brescia, Italy.
Cattelan A; Division of Infectious and Tropical Diseases, Azienda Ospedaliera and University of Padova, Italy.
Citriniti G; Rheumatology Unit, Department of Medical and Surgical Science, University of Modena, Azienda Policlinico of Modena, Italy.
Cristini F; Infectious Diseases Unit, Teaching Hospital S. Orsola-Malpighi, Alma Mater Studiorum University of Bologna, Italy.
De Rosa F; Department of Medical Science, University of Turin, Infectious Diseases Amedeo di Savoia Hospital, Turin, Italy.
Fracassi E; Rheumatology Section, Department of Medicine, University of Verona, Italy.
Galloway J; Academic Department of Rheumatology, King's College London, UK.
La Paglia GMC; Rheumatology Unit, University of Perugia, Italy.
Moioli MC; ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Ripamonti D; Division of Infectious Diseases, ASST Papa Giovanni XIII, Bergamo, Italy.
Saracino A; Clinic of Infectious Diseases, University of Bari, Italy.
Tani C; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Tascini C; First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Napoli, Italy.
Tieghi T; Infectious Diseases Unit, Sapienza University, S.M. Goretti Hospital, Latina, Italy.
Tinelli M; Division of Infectious and Tropical Diseases, Hospital of Lodi, Italy.
Zabotti A; Rheumatology Clinic, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy.
Sarzi-Puttini P; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Galli M; Infectious Disease Unit, Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Italy. .
Pokaż więcej
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2020 Mar-Apr; Vol. 38 (2), pp. 245-256. Date of Electronic Publication: 2019 Aug 27.
Typ publikacji :
Journal Article
MeSH Terms :
Vaccination*/standards
Influenza Vaccines/*administration & dosage
Pneumococcal Vaccines/*administration & dosage
Rheumatic Diseases/*immunology
Adult ; Autoimmune Diseases/complications ; Autoimmune Diseases/drug therapy ; Consensus ; Evidence-Based Medicine/methods ; Female ; Humans ; Immunosuppressive Agents/adverse effects ; Influenza Vaccines/immunology ; Influenza, Human/immunology ; Influenza, Human/prevention & control ; Italy ; Male ; Pneumococcal Vaccines/immunology ; Pneumonia, Staphylococcal/immunology ; Pneumonia, Staphylococcal/prevention & control ; Rheumatic Diseases/complications ; Rheumatic Diseases/drug therapy
Czasopismo naukowe
Tytuł :
Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01.
Autorzy :
Pinto D; Institute for Research in Biomedicine, Bellinzona 6500, Ticino, Switzerland.
Fenwick C; Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
Caillat C; Institut de Biologie Structurale (IBS), University Grenoble Alpes, CEA, CNRS, 38000 Grenoble, France.
Silacci C; Institute for Research in Biomedicine, Bellinzona 6500, Ticino, Switzerland.
Guseva S; Institut de Biologie Structurale (IBS), University Grenoble Alpes, CEA, CNRS, 38000 Grenoble, France.
Dehez F; LPCT, UMR 7019 Université de Lorraine CNRS, 54500 Vandœuvre-lès-Nancy, France; Laboratoire International Associé CNRS and University of Illinois at Urbana-Champaign, LPCT, UMR 7019 Universiteé de Lorraine CNRS, Vandœuvre-lès-Nancy 54500, France.
Chipot C; LPCT, UMR 7019 Université de Lorraine CNRS, 54500 Vandœuvre-lès-Nancy, France; Laboratoire International Associé CNRS and University of Illinois at Urbana-Champaign, LPCT, UMR 7019 Universiteé de Lorraine CNRS, Vandœuvre-lès-Nancy 54500, France; Department of Physics, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Barbieri S; Institute for Research in Biomedicine, Bellinzona 6500, Ticino, Switzerland.
Minola A; Humabs Biomed SA, Vir Biotechnology, 6500 Bellinzona, Ticino, Switzerland.
Jarrossay D; Institute for Research in Biomedicine, Bellinzona 6500, Ticino, Switzerland.
Tomaras GD; Duke Human Vaccine Institute, Durham, NC 27710, USA; Paris Diderot University, Sorbonne Paris Cité, Paris 75013, France.
Shen X; Duke Human Vaccine Institute, Durham, NC 27710, USA.
Riva A; Department of Biomedical and Clinical Sciences, Luigi Sacco University Hospital, Università di Milano, 20157 Milan, Italy; III Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, 20157 Milan, Italy.
Tarkowski M; Department of Biomedical and Clinical Sciences, Luigi Sacco University Hospital, Università di Milano, 20157 Milan, Italy.
Schwartz O; Institut Pasteur, Virus & Immunity Unit, CNRS UMR 3569, Paris 75015, France; Vaccine Research Institute, 94000 Créteil, France.
Bruel T; Institut Pasteur, Virus & Immunity Unit, CNRS UMR 3569, Paris 75015, France; Vaccine Research Institute, 94000 Créteil, France.
Dufloo J; Institut Pasteur, Virus & Immunity Unit, CNRS UMR 3569, Paris 75015, France; Vaccine Research Institute, 94000 Créteil, France; Paris Diderot University, Sorbonne Paris Cité, Paris 75013, France.
Seaman MS; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Lanzavecchia A; Institute for Research in Biomedicine, Bellinzona 6500, Ticino, Switzerland.
Corti D; Humabs Biomed SA, Vir Biotechnology, 6500 Bellinzona, Ticino, Switzerland. Electronic address: .
Pantaleo G; Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland. Electronic address: .
Weissenhorn W; Institut de Biologie Structurale (IBS), University Grenoble Alpes, CEA, CNRS, 38000 Grenoble, France. Electronic address: .
Pokaż więcej
Źródło :
Cell host & microbe [Cell Host Microbe] 2019 Nov 13; Vol. 26 (5), pp. 623-637.e8. Date of Electronic Publication: 2019 Oct 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Neutralizing/*immunology
HIV Antibodies/*immunology
HIV Envelope Protein gp41/*immunology
HIV-1/*immunology
AIDS Vaccines/immunology ; Amino Acid Sequence/genetics ; Animals ; Cell Line ; Disease Models, Animal ; Female ; HEK293 Cells ; Humans ; Mice ; Mice, Transgenic ; Protein Domains/immunology
Czasopismo naukowe
Tytuł :
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis.
Autorzy :
Sebastiani M; Rheumatology Unit, Department of Medical and Surgical Science, University of Modena, Azienda Policlinico of Modena, Modena, Italy.
Milazzo L; Infectious Diseases Unit, University of Milano, Luigi Sacco Hospital, Milan, Italy.
Atzeni F; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Vacchi C; Rheumatology Unit, Department of Medical and Surgical Science, University of Modena, Azienda Policlinico of Modena, Modena, Italy.
Manfredi A; Rheumatology Unit, Department of Medical and Surgical Science, University of Modena, Azienda Policlinico of Modena, Modena, Italy.
Quartuccio L; Department of Medical and Biological Sciences, Rheumatology Clinic, University of Udine, Udine, Italy.
Scirè C; Epidemiology Unit, Italian Society for Rheumatology (SIR), Milan, Italy.
Gaeta GB; Infectious Diseases and Viral Hepatitis Unit, Department of Internal and Specialistic Medicine, Second University of Naples, Naples, Italy.
Lapadula G; Department of Medicine - Rheumatology Unit, Medical School, University of Bari, Bari, Italy.
Armignacco O; Infectious Disease Unit, Belcolle Hospital, Viterbo, Italy.
Tavio M; Unit of Emerging and Immunosuppressed Infectious Diseases, Department of Gastroenterology and Transplantation, Azienda Ospedaliero-Universitaria 'Ospedali Riuniti', Torrette Ancona, Italy.
D'Angelo S; Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy.
Meroni P; Division of Rheumatology, Department of Clinical Sciences and Community Health, Gaetano Pini Orthopedic Institute, University of Milan, Milan, Italy.
Bazzichi L; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Grassi W; Department of Rheumatology, Università Politecnica delle Marche, Ospedale 'C. Urbani', Jesi Ancona, Italy.
Mathieu A; Rheumatology Unit, University Clinic and AOU of Cagliari, Cagliari, Italy.
Mastroianni C; Infectious Diseases Unit, Department Public Health and Infectious Disease, 'Sapienza' University of Rome, Rome, Italy.
Sagnelli E; Department of Mental Health and Public Medicine, Second University of Naples, Naples, Italy.
Santantonio T; Clinic of Infectious Diseases, University of Foggia, Foggia, Italy.
Foppa CU; Department of Infectious Diseases, San Raffaele Scientific Institute, Università Vita-Salute, Milan, Italy.
Puoti M; Department of Infectious Diseases, AO Niguarda Ca' Granda, Milano, Italy.
Sarmati L; Clinical Infectious Diseases, Tor Vergata University, Rome, Italy.
Airò P; Rheumatology and Clinical Immunology Unit, Spedali Civili of Brescia, Brescia, Italy.
Epis OM; Rheumatology Unit, A.O. Ospedale Niguarda Cà Granda, Milan, Italy.
Scrivo R; Department of Internal Medicine and Medical Specialties-Rheumatology Unit, Sapienza University of Rome, Rome, Italy.
Gargiulo M; Third Department of Infectious Diseases- D. Cotugno Hospital- AORN dei Colli, Naple, Italy.
Riva A; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Ciancio G; Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Sant'Anna University Hospital, Ferrara, Italy.
Zehender G; Chair of Hygiene, University of Milan, Milan, Italy.
Taliani G; Infectious Diseases Unit, Department Public Health and Infectious Disease, 'Sapienza' University of Rome, Rome, Italy.
Meroni L; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Sollima S; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Sarzi-Puttini P; Infectious Diseases Unit, University of Milano, Luigi Sacco Hospital, Milan, Italy.
Galli M; Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Pokaż więcej
Źródło :
Modern rheumatology [Mod Rheumatol] 2019 Nov; Vol. 29 (6), pp. 895-902. Date of Electronic Publication: 2019 Jan 22.
Typ publikacji :
Journal Article
MeSH Terms :
Practice Guidelines as Topic*
Antiviral Agents/*therapeutic use
Arthritis, Rheumatoid/*complications
Hepatitis C, Chronic/*drug therapy
Antirheumatic Agents/administration & dosage ; Antirheumatic Agents/therapeutic use ; Antiviral Agents/administration & dosage ; Arthritis, Rheumatoid/drug therapy ; Consensus ; Evidence-Based Medicine ; Hepatitis C, Chronic/complications ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/therapeutic use ; Italy
Czasopismo naukowe
Tytuł :
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort.
Autorzy :
Focà E; Division of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Magro P; Division of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Guaraldi G; Infectious Diseases Clinic, Department of Mother, Child and Adult Medicine and Surgical Science, University of Modena and Reggio Emilia, Modena, Italy.
Riva A; Third Division of Infectious Diseases, University of Milan, Ospedale L. Sacco, Milano, Italy.
Cattelan AM; Unit of Infectious Diseases, Department of Internal Medicine, Azienda Ospedaliera-Universitaria di Padova, Padova, Italy.
De Socio GV; Department of Infectious Diseases, Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy.
Costa C; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.
Piconi S; First Division of Infectious Diseases Unit, University of Milan, Ospedale L. Sacco, Milan, Italy.
Celesia BM; Division of Infectious Diseases, University of Catania, ARNAS Garibaldi, Catania, Italy.
Nozza S; Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
Orofino G; Unit of Infectious Diseases, Division A, Ospedale Amedeo di Savoia, Turin, Italy.
Castagna A; Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
Di Perri G; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.
Castelli F; Division of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Calcagno A; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy.
Pokaż więcej
Corporate Authors :
GEPPO (GEriatric Patients living with HIV/AIDS: a Prospective Multidimensional cOhort) Study Group
Źródło :
PloS one [PLoS One] 2019 Oct 17; Vol. 14 (10), pp. e0222225. Date of Electronic Publication: 2019 Oct 17 (Print Publication: 2019).
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Bone Diseases/*epidemiology
CD4-Positive T-Lymphocytes/*drug effects
HIV Infections/*epidemiology
HIV-1/*drug effects
Aged ; Aged, 80 and over ; Anti-HIV Agents/administration & dosage ; Bone Diseases/complications ; Bone Diseases/pathology ; Bone Diseases/virology ; CD4-Positive T-Lymphocytes/virology ; Cardiovascular Diseases/complications ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/pathology ; Cardiovascular Diseases/virology ; Cohort Studies ; Drug Therapy, Combination ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/virology ; HIV Seropositivity/blood ; HIV Seropositivity/virology ; HIV-1/pathogenicity ; Humans ; Male ; RNA, Viral/genetics ; Sex Characteristics ; Viral Load/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies